Dexcom Inc. Stock
€128.74
Your prediction
Dexcom Inc. Stock
Pros and Cons of Dexcom Inc. in the next few years
Pros
Cons
Performance of Dexcom Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Dexcom Inc. | -0.260% | 2.045% | -0.402% | 13.909% | 14.987% | 50.134% | 389.506% |
Dentsply Sirona Inc. | -1.770% | -1.014% | -6.662% | -24.210% | -12.057% | -48.263% | -36.915% |
Zimmer Holdings | 0.620% | -2.871% | -3.981% | -10.182% | 3.045% | -22.786% | 7.441% |
Baxter International | -3.390% | 0.698% | -2.698% | -9.396% | 7.019% | -48.799% | -44.610% |
Comments
News
Dexcom Reports First Quarter 2024 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2024.
First Quarter 2024 Financial Highlights:
-
Revenue grew 24% year-over-year to
2 Growth Stocks to Buy Hand Over Fist in April
Earnings season, which is fast approaching, is often somewhat volatile for the stock market. Companies that overdeliver or fail to deliver can see their share prices move significantly overnight.
Dexcom Publishes Annual Sustainability Report
DexCom, Inc. (NASDAQ:DXCM), the leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today released its annual Sustainability Report. This report provides updates on